Signaling Pathways - Sphingosine kinases (SphKs) - P-glycoprotein (P-gp) - Heparanases - adrenoceptor
清除全部
- B7157 OGT 2115Target: HeparanasesSummary: 乙酰肝素酶抑制剂
- B6552 CGP 20712 dihydrochlorideTarget: adrenoceptorSummary: β1拮抗剂
- B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂
- B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂
- A8549 LY335979 (Zosuquidar 3HCL)1 Citation中文名: 唑喹达三盐酸盐Target: P-glycoprotein (P-gp)Summary: Pgb(P糖蛋白)抑制剂
- A8474 Mirabegron (YM178)中文名: 米拉贝隆Target: adrenoceptorSummary: 选择性β3肾上腺素受体激动剂
- A3956 ZosuquidarTarget: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)Summary: MDR调节剂
- A3859 Tariquidar methanesulfonate, hydrate中文名: 他立喹达二甲磺酸盐六水合物Target: P-glycoprotein (P-gp)Summary: P-糖蛋白抑制剂
- A3717 PF-5431 CitationTarget: Sphingosine kinases (SphKs)Summary: SphK1选择性抑制剂
- A3384 Elacridar中文名: 依克立达Target: P-glycoprotein (P-gp)Summary: BCRP抑制剂